BMJ Open Submission Process

This page is about workflow after you decide to submit.

Use it when you want to understand:

• what happens after upload
• how editorial triage works at a methods-first journal
• what open review changes in practice
• where papers tend to stall before or after peer review

If you still need help deciding whether the package itself is ready, that belongs on the submission-guide page.

BMJ’s own author hub spells out the early process more clearly than many journals do:

1. an Editorial Production Assistant performs quality checks first
2. the paper then moves into the journal’s peer-review workflow
3. authors can track status through BMJ’s “Where Is My Paper?” tool instead of relying only on ScholarOne-style status labels
4. for most articles, BMJ says a minimum of two reviews is required
5. BMJ’s generic workflow says reviewers are given two weeks to submit once secured

That matters because it explains why some early quiet periods are quality-control or routing stages, not pure reviewer delay.

The process goes better when the manuscript already behaves like a BMJ Open paper before the portal opens:

• the reporting is complete enough to stand in public
• the claims are honest about the design
• the team is actually comfortable with open review and public manuscript history

That is why the workflow question starts before upload.

The early stage is not just an admin check. Editors are effectively testing whether:

• the study question is clear
• the reporting discipline is real rather than cosmetic
• the design supports the claim level
• the package can withstand transparent scrutiny

That is why technically complete submissions can still fail quickly.

In our pre-submission review work, BMJ Open submissions usually slow down when:

• the manuscript is being treated as a fallback journal submission rather than rewritten for a soundness-first audience
• the reporting checklist is attached, but the paper still leaves core methods or sample-size logic harder to verify than it should
• the conclusions are calmer than a prestige-journal draft but still slightly stronger than the design can support
• the team is not fully prepared for transparent review history and public reviewer exchange if the paper is accepted

Before upload, make sure the paper is being submitted as the right kind of article and that the relevant reporting standard is already reflected in the manuscript. For BMJ Open, this matters because the journal is strongly method-and-reporting sensitive.

The strongest BMJ Open submissions feel operationally clean. That usually means:

• reporting checklist ready
• ethics language finalized
• funding and disclosure sections complete
• figures and tables aligned with the manuscript text
• methods detailed enough that reviewers do not feel the paper is hiding anything

The mechanical process is ordinary enough: metadata, author details, manuscript upload, declarations, checklist attachments, then final confirmation. The more important point is what the package communicates while you do it.

BMJ Open is not using the same novelty filter as a more selective medical title. But that does not mean the first screen is loose.

Editors still ask:

• is the research question clear
• is the reporting complete enough
• is the study design acceptable for the claim
• does the conclusion stay inside the evidence

If the paper fails there, broader scope will not save it.

BMJ does something useful here: it documents the actual status ladder authors move through after upload.

The usual path is:

1. Awaiting Editorial Production Assistant Processing
2. Awaiting Editor Assignment
3. Awaiting Reviewer Selection
4. Peer Review in Progress
5. Awaiting Editor Decision
6. In Production

That is much better than trying to interpret vague status text without context. It also means a period of silence can be normal even when the manuscript is moving.

If the paper reaches the end of the abstract without saying what it really tested, the process gets harder immediately.

BMJ Open reviewers expect openness about limitations, methods, and uncertainty. Hidden ambiguity reads badly here.

The journal is comfortable with many study types, but reviewers still punish papers that claim causal force from weaker designs without the right caveats.

A broad-scope journal is still a serious journal. Missing tables, weak methods explanation, or an unstable supplement package create avoidable friction.

BMJ Open publishes review-speed stats, but authors still misread the quiet periods.

• early quiet usually means suitability, completeness, and reporting discipline are being judged
• long waits with review usually reflect the reality of open review and thorough methods-focused feedback
• a rapid no is often a package-quality or fit judgment, not proof the research question was worthless

BMJ Open’s own public author page currently reports:

• 134 days median time to first decision with review
• 27% acceptance rate

That combination matters. It is not a near-automatic venue, but it is also not pretending to be a novelty-first flagship. The process is selective enough that getting to external review is meaningful, and slow enough that authors should plan for a real methods-and-reporting review cycle.

The useful question is not just how many days have passed. It is what the journal is plausibly evaluating right now.

BMJ Open’s transparency model matters before review, but it matters even more once the article is accepted.

For accepted papers, BMJ Open publishes:

• reviewer comments
• author responses
• previous manuscript versions used during peer review

So the process question is not just "can this paper survive review?" It is also "will the review history read as evidence of a disciplined, trustworthy paper once it is public?"

The most common drag points are not mysterious.

One is checklist mismatch. The authors think they have complied with the relevant reporting standard, but the manuscript still leaves out information reviewers expect to see quickly. That creates unnecessary back-and-forth.

Another is weak operational consistency. Tables, abstract, methods, supplement, and stated sample-size logic all need to line up. BMJ Open reviewers are very capable of spotting when the statistical story and the written story are not describing the same study with the same level of confidence.

The last common problem is emotional positioning. Teams often submit to BMJ Open after a rejection elsewhere but forget to rewrite the paper for a soundness-first journal. If the manuscript still reads like a disappointed prestige-journal draft, the submission process gets rougher than it needs to.

In our pre-submission review work with BMJ Open-bound manuscripts, the process problems are usually visible before submission. We check whether the manuscript gives BMJ's Editorial Production Assistant and handling editor a clean path through the first two gates.

The easiest way to think about a good BMJ Open submission is that nothing in the package should feel evasive.

A strong package usually has:

• a direct abstract that names the study design honestly
• a methods section that answers obvious reviewer questions before they are asked
• reporting language that stays proportional to the data
• a supplement that looks complete rather than improvised
• a cover letter that explains why the study belongs in BMJ Open without pretending the journal is using a novelty filter it does not use

That is why BMJ Open can be attractive for good, solid studies. If the methods are strong and the reporting is disciplined, the process can work in your favor. If the paper still relies on ambiguity, the journal's openness can become a problem quickly.

Run the manuscript through BMJ Open submission readiness check to catch reporting and structural gaps, or at minimum check the following.

One last practical test helps here: give the abstract, methods summary, and checklist to someone outside the author team and ask them what the study actually did. If they cannot answer cleanly, the submission package is still not sharp enough for BMJ Open.

That sounds basic, but it catches exactly the kind of unclear reporting that makes a sound study look weaker than it is.

The most useful way to think about this journal is that it is not asking whether the study is glamorous. It is asking whether the study is clear, methodologically credible, and responsibly interpreted.

That means the best BMJ Open submissions often look calmer than authors expect. They are explicit about limitations, specific about methods, and less interested in selling novelty than in demonstrating trustworthiness.